Howd is a Director of Malin Corporation plc ("Malin"). Malin is an Irish incorporated public limited company which applies its long term capital and proven operational and strategic expertise to a select number of private life science companies. Previously, Dr Howd has held both sell-side and buy-side roles, being a highly ranked sell-side analyst at Berenberg, Nomura and ABN Amro where he was Global Head of Healthcare Research. He also gained buy-side experience running a healthcare portfolio as part of the Principal Strategies Group at ABN Amro. Dr. Howd also served as Executive Vice President, Head of Neuroscience and Corporate Development at Evotec AG. Dr. Howd has a PhD in molecular neuroscience from the University of London.  Howd is a Director of Malin Corporation plc ("Malin"). Malin is an Irish incorporated public limited company which applies its long term capital and proven operational and strategic expertise to a select number of private life science companies. Previously, Dr Howd has held both sell-side and buy-side roles, being a highly ranked sell-side analyst at Berenberg, Nomura and ABN Amro where he was Global Head of Healthcare Research. He also gained buy-side experience running a healthcare portfolio as part of the Principal Strategies Group at ABN Amro. Dr. Howd also served as Executive Vice President, Head of Neuroscience and Corporate Development at Evotec AG. Dr. Howd has a PhD in molecular neuroscience from the University of London.

fermentation